Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus- A Cost-Effectiveness Model
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.893
https://www.valueinhealthjournal.com/article/S1098-3015(17)31227-5/fulltext
Title :
Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus- A Cost-Effectiveness Model
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31227-5&doi=10.1016/j.jval.2017.08.893
First page :
A556
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
852